12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga·04/04/2025 12:05:45

Listen to the news

Gainers

Impact BioMedical (AMEX:IBO) stock increased by 80.6% to $0.84 during Friday's pre-market session. The market value of their outstanding shares is at $9.6 million.
Biodexa Pharmaceuticals (NASDAQ:BDRX) shares rose 25.15% to $1.84. The market value of their outstanding shares is at $1.2 million.
Entero Therapeutics (NASDAQ:ENTO) stock moved upwards by 23.77% to $0.54. The market value of their outstanding shares is at $2.5 million.
Sangamo Therapeutics (NASDAQ:SGMO) shares moved upwards by 23.73% to $0.77. The market value of their outstanding shares is at $173.0 million.
Kairos Pharma (AMEX:KAPA) shares moved upwards by 14.89% to $1.08. The company's market cap stands at $14.7 million.
ZyVersa Therapeutics (NASDAQ:ZVSA) stock moved upwards by 12.06% to $0.68. The company's market cap stands at $1.7 million.

Losers

KORU Medical Systems (NASDAQ:KRMD) shares declined by 57.2% to $1.01 during Friday's pre-market session. The company's market cap stands at $46.4 million.
NeuroOne Medical Tech (NASDAQ:NMTC) stock fell 41.28% to $0.51. The market value of their outstanding shares is at $15.5 million.
XOMA Royalty (NASDAQ:XOMAP) shares decreased by 35.09% to $16.71.
Nexalin Technology (NASDAQ:NXL) shares declined by 30.39% to $1.26. The market value of their outstanding shares is at $16.7 million.
Dianthus Therapeutics (NASDAQ:DNTH) shares decreased by 23.34% to $13.01. The company's market cap stands at $417.9 million.
Maze Therapeutics (NASDAQ:MAZE) stock fell 22.75% to $7.2. The market value of their outstanding shares is at $315.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English